Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies

被引:28
作者
Fitzgerald, Mary F.
Fox, J. Craig
机构
[1] Flex Meadow, Harlow, CM19 5TR
关键词
D O I
10.1016/j.drudis.2007.04.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease that is characterized by progressive airway obstruction that, unlike asthma, is relatively insensitive to bronchodilators and to the classic anti-inflammatory therapy, corticosteroids. In this review we consider the potential of bronchodilator drugs and corticosteroid drugs that are in clinical development for COPD and discuss how the best treatments might be achieved with combinations of drugs that are either already launched or close to launch.
引用
收藏
页码:472 / 478
页数:7
相关论文
共 53 条
  • [1] AARON SD, ANN INTERN MED
  • [2] One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium
    Anzueto, A
    Tashkin, D
    Menjoge, S
    Kesten, S
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (02) : 75 - 81
  • [3] Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
    Barnes, NC
    Qiu, YS
    Pavord, ID
    Parker, D
    Davis, PA
    Zhu, L
    Johnson, M
    Thomson, NC
    Jeffery, PK
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (07) : 736 - 743
  • [4] Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis
    Barr, R. G.
    Bourbeau, J.
    Camargo, C. A.
    Ram, F. S. F.
    [J]. THORAX, 2006, 61 (10) : 854 - 862
  • [5] BAUMGARTNER RA, 2006, P AM THORAC SOC, V3, pA847
  • [6] BONE R, 1994, CHEST, V105, P1411
  • [7] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    [J]. LANCET, 2003, 361 (9356) : 449 - 456
  • [8] Calverley Peter M A, 2004, Proc Am Thorac Soc, V1, P121, DOI 10.1513/pats.2306031
  • [9] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) : 775 - 789
  • [10] Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
    Calverley, PM
    Boonsawat, W
    Cseke, Z
    Zhong, N
    Peterson, S
    Olsson, H
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) : 912 - 919